Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

BioArctic AB Class B (0RV2) Price & Analysis

0RV2 Stock Chart & Stats

SEK 319.20-SEK 1.60(-0.50%)
At close: 4:00 PM EDT
SEK 300SEK 325SEK 3503 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
SEK 319.00 - SEK 319.20
52-Week Range
SEK 258.80 - SEK 364.40
Previous Close
SEK 320.80
Volume
2,683
Average Volume (3M)
6,716
Market Cap
SEK 28.15B
Enterprise Value
SEK 27.31B
Total Cash (Recent Filing)
SEK 1.99B
Total Debt (Recent Filing)
SEK 90.61M
Price to Earnings (P/E)
266.6
Beta
0.51
Next Earnings
Nov 25, 2026
EPS Estimate
0.26
Next Dividend Ex-Date
N/A
Dividend Yield
0.65%

Bulls Say, Bears Say

Bulls Say

Low Leverage

Very low leverage limits financial risk and reduces the burden of interest or refinancing obligations. A strong equity base gives BioArctic greater flexibility to continue research, support partnered programs, and absorb earnings fluctuations without relying heavily on additional debt.

Strong Profitability

The current margin and profitability profile indicates that BioArctic can generate meaningful earnings from its business activities. Strong gross and operating profitability can provide internal funding for innovation while improving resilience during periods of uneven revenue or development timing.

Partner-funded Model

BioArctic’s partnering model allows larger pharmaceutical companies to finance substantial development, regulatory, and commercialization activities. This can reduce the company’s need to build a large sales organization or fund the full late-stage cost burden internally, supporting capital efficiency.

Bears Say

Revenue Contraction

A sharp decline in the revenue run-rate weakens near-term visibility into the company’s recurring earning base. Because partnering revenue can depend on milestones and collaboration timing, sustained contraction would make it harder to plan investment and demonstrate consistent commercial progress.

Volatile Cash Generation

Although current cash generation remains positive, the large year-to-year swings show that cash conversion is not yet dependable. Periods of negative operating and free cash flow could constrain internally funded research and increase reliance on partnership receipts or other financing sources.

Earnings Volatility

The pronounced swings in annual profitability make BioArctic’s earnings power less predictable than that of a mature business. Such variability can complicate resource allocation, obscure underlying operating trends, and leave results sensitive to the timing of partnerships, milestones, or development activities.

BioArctic AB Class B News

0RV2 FAQ

What was BioArctic AB Class B’s price range in the past 12 months?
BioArctic AB Class B lowest share price was kr 258.80 and its highest was kr 364.40 in the past 12 months.
What is BioArctic AB Class B’s market cap?
BioArctic AB Class B’s market cap is kr 28.15B.
When is BioArctic AB Class B’s upcoming earnings report date?
BioArctic AB Class B’s upcoming earnings report date is Nov 25, 2026 which is in 24 days.
How were BioArctic AB Class B’s earnings last quarter?
BioArctic AB Class B released its earnings results on Aug 26, 2026. The company reported -kr 0.13 earnings per share for the quarter, beating the consensus estimate of -kr 0.335 by kr 0.205.
Is BioArctic AB Class B overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does BioArctic AB Class B pay dividends?
BioArctic AB Class B does not currently pay dividends.
What is BioArctic AB Class B’s EPS estimate?
BioArctic AB Class B’s EPS estimate is 0.26.
How many shares outstanding does BioArctic AB Class B have?
BioArctic AB Class B has 74,344,690 shares outstanding.
What happened to BioArctic AB Class B’s price movement after its last earnings report?
BioArctic AB Class B reported an EPS of -kr 0.13 in its last earnings report, beating expectations of -kr 0.335. Following the earnings report the stock price went down -7.379%.
Which hedge fund is a major shareholder of BioArctic AB Class B?
Currently, no hedge funds are holding shares in GB:0RV2
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology